IP Library Granted Patent US 8,993,328
Granted Patent B2
US 8,993,328 · App. 12/564,903 · Granted Mar 31, 2015

Media conditioning for improving gene delivery efficiency to differentiating embryonic stem cells

Inventors: Martin L. Yarmush (Piscataway, NJ); Eric J. Wallenstein (Morris Plains, NJ); Rene S. Schloss (East Brunswick, NJ)
Assignee: Rutgers, The State University of New Jersey
C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,328
App. No.
12/564,903
Granted
Mar 31, 2015
Kind
B2
Abstract

The present invention provides systems and methods for improving the efficiency of a transient gene delivery system to differentiating embryonic stem (ES) cells by serum starving the targeted cells for one to three days prior to transfection. Such a serum starvation surprisingly resulted in increased expression of a constitutively-controlled plasmid from 50.4% to 83.2% of the population and increased expression of a promoter/enhancer controlled plasmid from ˜1.4% to ˜3.7% of the population.

Claims (8)

1. A method for delivering a non-viral plasmid vector to a differentiating embryonic stem cell comprising:

culturing a differentiating human or murine embryonic stem cell in a serum starved condition for about 1 to about 3 days,

delivering to the cell cultured in the serum starved condition a non-viral plasmid vector encoding and capable of expressing a bioactive agent; and

expressing the bioactive agent within the differentiating embryonic stem cell.

2. The method of claim 1 wherein the cell is a differentiating human embryonic stem cell.

3. The method of claim 2 further comprising the step of isolating the embryonic stem cell from an embryoid body prior to the culturing step.

4. The method of claim 1 wherein the cells are cultured on IMDM media having 0.5% or less of fetal bovine serum.

5. The method of claim 1 wherein the cell is a differentiating murine embryonic stem cell.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 20, 2023
From: RUTGERS, THE STATE UNIVERSITY OF N.J.
To: NIH - DEITR; NSF - DEITR
Reel/Frame 064976/0436 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2015
From: YARMUSH, MARTIN L.; WALLENSTEIN, ERIC J.; SCHLOSS, RENE S.
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 034983/0191 →
Continuity (2)
Provisional Application 61099007 · Sep 22, 2008
Related Publication 20100184226A1 · Jul 22, 2010